181 related articles for article (PubMed ID: 30592157)
1. Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling.
Kim NR; Kim YJ
Cancer Med; 2019 Jan; 8(1):276-288. PubMed ID: 30592157
[TBL] [Abstract][Full Text] [Related]
2. The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance.
Li J; Chen J; Zhang M; Zhang C; Wu R; Yang T; Qiu Y; Liu J; Zhu T; Zhang Y; Rong R
Front Immunol; 2021; 12():661338. PubMed ID: 33897705
[TBL] [Abstract][Full Text] [Related]
3. Decitabine suppresses MDSC-induced immunosuppression through dual functional mechanism and inhibits melanoma metastasis.
Zhang Z; Wang T; Fang G; Xiao X; Zhang Z; Zhao J
Med Oncol; 2024 May; 41(7):165. PubMed ID: 38819590
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
[TBL] [Abstract][Full Text] [Related]
5. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
6. Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice.
Ostrand-Rosenberg S; Sinha P; Figley C; Long R; Park D; Carter D; Clements VK
J Leukoc Biol; 2017 May; 101(5):1091-1101. PubMed ID: 28007981
[TBL] [Abstract][Full Text] [Related]
7. Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway.
Zhang S; Wu K; Liu Y; Lin Y; Zhang X; Zhou J; Zhang H; Pan T; Fu Y
PLoS One; 2016; 11(6):e0156549. PubMed ID: 27253400
[TBL] [Abstract][Full Text] [Related]
8. TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host.
Song G; Zhang Y; Tian J; Ma J; Yin K; Xu H; Wang S
Front Immunol; 2021; 12():649020. PubMed ID: 33717204
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjögren's syndrome.
Wei Y; Peng N; Deng C; Zhao F; Tian J; Tang Y; Yu S; Chen Y; Xue Y; Xiao F; Zhou Y; Li X; Zou H; Rui K; Lin X; Lu L
Cell Mol Immunol; 2022 Dec; 19(12):1361-1372. PubMed ID: 36369368
[TBL] [Abstract][Full Text] [Related]
10. Swertianolin ameliorates immune dysfunction in sepsis via blocking the immunosuppressive function of myeloid- derived suppressor cells.
Ren Z; Tang H; Wan L; Liu X; Tang N; Wang L; Guo Z
Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34468107
[TBL] [Abstract][Full Text] [Related]
11. Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.
Belyaev NN; Abdolla N; Perfilyeva YV; Ostapchuk YO; Krasnoshtanov VK; Kali A; Tleulieva R
Cancer Immunol Immunother; 2018 Jan; 67(1):101-111. PubMed ID: 28956104
[TBL] [Abstract][Full Text] [Related]
12. Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
Bazargan S; Bunch B; Ojwang' AME; Blauvelt J; Landin A; Ali J; Abrahams D; Cox C; Hall AM; Beatty MS; Poch M; Rejniak KA; Pilon-Thomas S
Front Immunol; 2023; 14():1275375. PubMed ID: 37901214
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways.
van Wigcheren GF; Cuenca-Escalona J; Stelloo S; Brake J; Peeters E; Horrevorts SK; Frölich S; Ramos-Tomillero I; Wesseling-Rozendaal Y; van Herpen CML; van de Stolpe A; Vermeulen M; de Vries IJM; Figdor CG; Flórez-Grau G
J Biol Chem; 2023 Nov; 299(11):105276. PubMed ID: 37739035
[TBL] [Abstract][Full Text] [Related]
14. MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers.
Fultang L; Panetti S; Ng M; Collins P; Graef S; Rizkalla N; Booth S; Lenton R; Noyvert B; Shannon-Lowe C; Middleton G; Mussai F; De Santo C
EBioMedicine; 2019 Sep; 47():235-246. PubMed ID: 31462392
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.
de Goeje PL; Bezemer K; Heuvers ME; Dingemans AC; Groen HJ; Smit EF; Hoogsteden HC; Hendriks RW; Aerts JG; Hegmans JP
Oncoimmunology; 2015 Jul; 4(7):e1014242. PubMed ID: 26140237
[TBL] [Abstract][Full Text] [Related]
16. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
Tongu M; Harashima N; Monma H; Inao T; Yamada T; Kawauchi H; Harada M
Cancer Immunol Immunother; 2013 Feb; 62(2):383-91. PubMed ID: 22926062
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.
Rodríguez-Ubreva J; Català-Moll F; Obermajer N; Álvarez-Errico D; Ramirez RN; Company C; Vento-Tormo R; Moreno-Bueno G; Edwards RP; Mortazavi A; Kalinski P; Ballestar E
Cell Rep; 2017 Oct; 21(1):154-167. PubMed ID: 28978469
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion.
Li X; Chen J; Chen YJ; Qiao YD; Zhao LY; Jiang N; Wu XY; Xing YF
Commun Biol; 2021 Feb; 4(1):252. PubMed ID: 33637832
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.
Pilatova K; Bencsikova B; Demlova R; Valik D; Zdrazilova-Dubska L
Cancer Immunol Immunother; 2018 Dec; 67(12):1919-1929. PubMed ID: 29748897
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.
Zhang W; Li J; Qi G; Tu G; Yang C; Xu M
J Transl Med; 2018 Jan; 16(1):19. PubMed ID: 29378596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]